Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)

NCT03653832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1437

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: Dexmedetomidine
DRUG: Clonidine
DRUG: Propofol

Sponsor

University of Edinburgh

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]